• LAST PRICE
    5.3400
  • TODAY'S CHANGE (%)
    Trending Down-0.4300 (-7.4523%)
  • Bid / Lots
    5.1000/ 31
  • Ask / Lots
    5.4400/ 85
  • Open / Previous Close
    5.5700 / 5.7700
  • Day Range
    Low 5.2000
    High 5.6500
  • 52 Week Range
    Low 2.3800
    High 11.9900
  • Volume
    237,771
    above average

Search Criteria

Filter search criteria using below inputs

Click on magnifying glass icon to search

Search Criteria - - - Stocks (0)
CompanyCountrySymbol
Select an index
Price Comparison Graph. See accessible table below
1 Day Comparison Chart Accessibility Table. Thursday's close: 5.77
TimeVolumeLTRN
09:32 ET48555.57
09:34 ET10325.6356
09:36 ET8005.61
09:38 ET10005.65
09:39 ET4905.55
09:41 ET6005.6039
09:43 ET1005.625
09:48 ET5905.6
09:50 ET10075.5
09:52 ET11005.51
09:54 ET4205.5001
09:59 ET1005.575
10:01 ET119435.5
10:03 ET109005.58
10:06 ET51945.6
10:10 ET35785.5
10:12 ET26965.5
10:14 ET1005.37
10:17 ET18005.4499
10:21 ET14995.4
10:24 ET4505.36
10:28 ET42005.3801
10:30 ET10605.36
10:32 ET7065.442
10:33 ET2005.4995
10:35 ET11005.52
10:37 ET95585.3101
10:39 ET13105.4958
10:48 ET45785.2
10:51 ET24175.338
10:53 ET19315.2702
10:55 ET41825.3108
10:57 ET18415.39
11:00 ET4405.4067
11:02 ET17005.3601
11:04 ET6015.4
11:09 ET1505.394
11:13 ET12005.42
11:15 ET7855.41
11:18 ET5585.4001
11:20 ET72505.405
11:22 ET1005.405
11:24 ET41285.39
11:26 ET1005.4423
11:29 ET6305.3601
11:33 ET5445.4
11:36 ET4005.4
11:38 ET1005.4
11:40 ET6005.405
11:44 ET2825.3687
11:47 ET1005.4406
11:49 ET27605.49
11:54 ET30005.44
11:58 ET2005.45
12:03 ET1005.45
12:09 ET1505.4554
12:16 ET1005.42
12:20 ET6455.4884
12:23 ET23075.45
12:27 ET5005.4196
12:43 ET5005.4899
12:52 ET2825.42
12:57 ET1005.4817
12:59 ET2005.4406
01:01 ET3505.4208
01:08 ET3255.435
01:12 ET31005.49
01:15 ET1455.5
01:17 ET12005.4306
01:19 ET33965.56
01:28 ET15005.5999
01:39 ET2005.527
01:51 ET1005.5527
02:04 ET16005.47
02:08 ET12005.46
02:15 ET1005.485
02:18 ET3265.485
02:22 ET4005.39
02:27 ET50005.415
02:33 ET2245.455
02:38 ET4005.41
02:42 ET14005.52
02:44 ET5005.505
02:45 ET1005.505
02:47 ET209705.35
02:51 ET3105.48
02:58 ET2005.3
03:00 ET7505.3001
03:05 ET2005.28
03:07 ET9005.22
03:14 ET1005.27
03:16 ET5005.4
03:18 ET66265.25
03:21 ET12305.28
03:25 ET2605.4
03:27 ET3005.43
03:30 ET11405.44
03:32 ET9025.43
03:34 ET62955.35
03:36 ET9405.3453
03:38 ET2005.43
03:39 ET5115.36
03:41 ET1005.42
03:43 ET46005.43
03:45 ET42845.36
03:48 ET6005.44
03:50 ET9305.33
03:52 ET3005.42
03:54 ET14725.38
03:56 ET79595.39
03:57 ET77835.42
03:59 ET83345.34
Data delayed at least 15 minutes.
Industry Peers Overview Table
Company sortableMarket Cap sortableP/E Ratio (TTM) sortableEPS Growth (5yr) sortable
United StatesLTRN
Lantern Pharma Inc
62.0M
-3.6x
---
United StatesRTGN
RetinalGenix Technologies Inc
62.2M
-29.1x
---
United StatesOKYO
OKYO Pharma Ltd
49.5M
-0.1x
---
United StatesRLYB
Rallybio Corp
63.1M
-1.0x
---
United StatesMURA
Mural Oncology PLC
60.4M
-0.3x
---
United StatesNVNO
enVVeno Medical Corp
63.7M
-2.4x
---
As of 2024-04-19

Company Information

Lantern Pharma Inc. is an artificial intelligence (AI) company. The Company is developing targeted and transformative cancer therapies using its proprietary RADR AI and machine learning (ML) platform with multiple clinical-stage drug programs. Its proprietary AI and machine learning (ML) platform, RADR, leverages over 60 billion oncology-focused data points and a library of over 200 advanced ML algorithms to help solve problems in oncology drug development. It is engaged in the development of its pipeline of therapies that span multiple cancer indications, including both solid tumors and blood cancers and an antibody drug conjugate (ADC) program. It has active clinical programs for its three lead small molecule drug candidates: LP-300, LP-184, and LP-284. These programs are focused on multiple cancer indications, including both solid tumors and blood cancers. It is also focused on the clinical execution of its therapies for CNS and brain cancers through Starlight Therapeutics Inc.

Contact Information

Headquarters
1920 MCKINNEY AVENUE, 7TH FLOORDALLAS, TX, United States 75201
Phone
972-277-1136
Fax
302-655-5049

Executives

Independent Chairman of the Board
Donald Keyser
President, Chief Executive Officer, Director
Panna Sharma
Chief Financial Officer, Secretary
David Margrave
Chief Scientific Officer
Kishor Bhatia
Chief Medical Officer
Marc Chamberlain

Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.

Open a New Account, or Login if you're a client.

You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.

Open a New Account, or Login if you're a client.

Fundamentals Table
Market Cap
$62.0M
Revenue (TTM)
$0.00
Shares Outstanding
10.7M
Dividend Yield
0.00%
Annual Dividend Rate
---
Ex-Dividend Date
01-01-01
Pay Date
01-01-01
Beta
1.53
EPS
$-1.47
Book Value
$3.82
P/E Ratio
-3.6x
Price/Sales (TTM)
---
Price/Cash Flow (TTM)
---
Operating Margin
---
*GAAP = prior to non-GAAP analyst adjusted earnings.

Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.

Open a New Account, or Login if you're a client.